Ligand validation:6EID

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6EID designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6EID_OLC_A_1107	33%	72%	0.107	0.936	0.47	0.6	-	-	0	0	16%	16
6EID_OLC_B_1101	16%	85%	0.184	0.843	0.5	0.24	-	-	0	0	52%	0.52
6EID_OLC_B_1105	16%	88%	0.278	0.897	0.45	0.22	-	-	1	0	72%	0.72
6EID_OLC_B_1102	13%	46%	0.327	0.898	1.1	1.03	1	2	0	0	84%	0.84
6EID_OLC_A_1104	12%	58%	0.265	0.872	0.57	1	-	1	0	0	60%	0.6
6EID_OLC_A_1102	12%	56%	0.273	0.855	0.7	0.99	-	2	0	0	72%	0.72
6EID_OLC_A_1101	9%	36%	0.232	0.792	1.4	1.19	1	2	0	0	64%	0.64
6EID_OLC_B_1103	8%	39%	0.339	0.866	1.18	1.26	1	2	0	0	76%	0.76
6EID_OLC_A_1108	7%	55%	0.343	0.892	0.58	1.13	-	1	0	0	48%	0.48
6EID_OLC_A_1106	5%	92%	0.225	0.755	0.44	0.1	-	-	0	0	32%	0.32
6EID_OLC_A_1105	5%	83%	0.343	0.791	0.46	0.32	-	-	0	0	72%	0.72
6EID_OLC_A_1103	3%	42%	0.308	0.701	1.28	1.04	1	2	0	0	72%	0.72
6EID_OLC_B_1104	2%	38%	0.388	0.676	1.39	1.12	1	2	0	0	72%	0.72
6EIG_OLC_B_1103	20%	48%	0.267	0.917	1.06	0.96	1	1	0	0	76%	0.76
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.